Olmesartan Is an Angiotensin II Receptor Blocker with an Inhibitory Effect on Angiotensin-Converting Enzyme-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Olmesartan Is an Angiotensin II Receptor Blocker with an Inhibitory Effect on Angiotensin-Converting Enzyme

Published:2006 Issue:11 Volume:29 Page:865-874
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

AGATA Jun,URA Nobuyuki,YOSHIDA Hideaki,SHINSHI Yasuyuki,SASAKI Haruki,HYAKKOKU Masaya,TANIGUCHI Shinya,SHIMAMOTO Kazuaki

Publisher

Japanese Society of Hypertension

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference37 articles.

1. A Human Homolog of Angiotensin-converting Enzyme

2. 2. Donoghue M, Hsieh F, Baronas E, et al: A novel angiotensin-converting enzyme−related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000; 87: e1-e9.

3. 4. Loot AE, Roks AJ, Henning RH, et al: Angiotenisn-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 2002; 105: 1548-1550.

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Forced Degradation Products of Olmesartan Medoxomil and their In Vitro Genotoxicity Assessment by Comet Assay using HEK Cells;ChemistrySelect;2024-04-25

2. ACE2 inhibits proliferation of smooth muscle cell through AT1R and its downstream signaling pathway;Journal of Biosciences;2023-07-27

3. Comparative antihypertensive efficacy of combinations of azilsartan medoxomil or olmesartan medoxomil with amlodipine in patients with arterial hypertension, type 2 diabetes mellitus and non-alcoholic fatty liver disease;South Russian Journal of Therapeutic Practice;2023-03-28

4. Preparation of polysubstituted imidazoles using AC-SO₃H/[Urea]₇[ZnCl₂]₂as an efficient catalyst system: a novel method, and α-glucosidase inhibitor activity;RSC Advances;2023

5. Classic vs. C–H functionalization strategies in the synthesis of APIs: a sustainability comparison;Green Chemistry;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3